--- title: "BAMC released its performance for the first three quarters, with a net profit attributable to the parent company of 881 million yuan, a year-on-year decrease of 19.76%" type: "News" locale: "en" url: "https://longbridge.com/en/news/262749311.md" description: "According to the Zhitong Finance APP, BAMC released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 15.474 billion yuan, a year-on-year increase of 6.07%. The net profit attributable to shareholders of the listed company was 881 million yuan, a year-on-year decrease of 19.76%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 881 million yuan, a year-on-year decrease of 16.73%" datetime: "2025-10-26T07:46:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/262749311.md) - [en](https://longbridge.com/en/news/262749311.md) - [zh-HK](https://longbridge.com/zh-HK/news/262749311.md) --- # BAMC released its performance for the first three quarters, with a net profit attributable to the parent company of 881 million yuan, a year-on-year decrease of 19.76% According to the Zhitong Finance APP, BAMC (601137.SH) released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 15.474 billion yuan, a year-on-year increase of 6.07%. The net profit attributable to shareholders of the listed company was 881 million yuan, a year-on-year decrease of 19.76%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 881 million yuan, a year-on-year decrease of 16.73% ### Related Stocks - [601137.CN](https://longbridge.com/en/quote/601137.CN.md) ## Related News & Research - [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md) - [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md) - [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md) - [11:23 ETTOUS les JOURS BRINGS OFFICIAL BTS THE CITY ARIRANG POP-UP EXPERIENCE TO LAS VEGAS BAKERY CAFÉS](https://longbridge.com/en/news/286793282.md) - [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)